Lack of Benefit on Brain Edema, Blood-Brain Barrier Permeability, or Cognitive Outcome in Global Inducible High Mobility Group Box 1 Knockout Mice Despite Tissue Sparing after Experimental Traumatic Brain Injury

Journal of Neurotrauma

Volumn 36, Issue 2, 2019, Pages 360-369

  Aneja, Rajesh K ^a   Alcamo, Alicia M ^a   Cummings, Jessica ^a   Vagni, Vincent ^a   Feldman, Keri ^a   Wang, Qingde ^a   Dixon, C Edward ^a   Billiar, Timothy R ^a   Kochanek, Patrick M ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

BBB permeability; cognitive impairment; HMGB1; traumatic brain injury

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CONTUSION; BRAIN EDEMA; BRAIN NERVE CELL; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; EXPERIMENTAL TRAUMATIC BRAIN INJURY; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; SPATIAL MEMORY; WILD TYPE; ANIMAL; CAPILLARY PERMEABILITY; COGNITIVE DEFECT; DISEASE MODEL; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRAUMATIC BRAIN INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURIES, TRAUMATIC; CAPILLARY PERMEABILITY; COGNITIVE DYSFUNCTION; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; MICE; MICE, KNOCKOUT;

EID: 85057018826     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2018.5664     Document Type: Article

References (44)

1. (2012). The changing landscape of traumatic brain injury research. Lancet Neurol. 11, 651.
2. Corps, K.N., Roth, T.L., and McGavern, D.B. (2015). Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 72, 355-362.
3. Bianchi, M.E. (2007). DAMPs, PAMPs and alarmins: All we need to know about danger. J. Leukoc. Biol. 81, 1-5.
4. Manson, J., Thiemermann, C., and Brohi, K. (2012). Trauma alarmins as activators of damage-induced inflammation. Br. J. Surg. 99 Suppl 1, 12-20.
5. Wang, H., Yang, H., Czura, C.J., Sama, A.E., and Tracey, K.J. (2001). HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164, 1768-1773.
6. Castiglioni, A., Canti, V., Rovere-Querini, P., and Manfredi, A.A. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell. Tissue Res. 343,189-199.
7. Gallucci, S. and Matzinger, P. (2001). Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119.
8. Peltz, E.D., Moore, E.E., Eckels, P.C., Damle, S.S., Tsuruta, Y., Johnson, J.L., Sauaia, A., Silliman, C.C., Banerjee, A., and Abraham, E. (2009). HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock 32, 17-22.
9. Park, J.S., Svetkauskaite, D., He, Q., Kim, J.Y., Strassheim, D., Ishizaka, A., and Abraham, E. (2004). Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377.
10. Yu, M., Wang, H., Ding, A., Golenbock, D.T., Latz, E., Czura, C.J., Fenton, M.J., Tracey, K.J., and Yang, H. (2006). HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174-179.
11. Pedrazzi, M., Patrone, M., Passalacqua, M., Ranzato, E., Colamassaro, D., Sparatore, B., Pontremoli, S., and Melloni, E. (2007). Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J. Immunol. 179, 8525-8532.
12. Laird, M.D., Shields, J.S., Sukumari-Ramesh, S., Kimbler, D.E., Fessler, R.D., Shakir, B., Youssef, P., Yanasak, N., Vender, J.R., and Dhandapani, K.M. (2014). High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 62, 26-38.
13. Au, A.K., Aneja, R.K., Bell, M.J., Bayir, H., Feldman, K., Adelson, P.D., Fink, E.L., Kochanek, P.M., and Clark, R.S. (2012). Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. J. Neurotrauma 29, 2013-2021.
14. Gao, T.L., Yuan, X.T., Yang, D., Dai, H.L., Wang, W.J., Peng, X., Shao, H.J., Jin, Z.F., and Fu, Z.J. (2012). Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury. J. Trauma Acute Care Surg. 72, 643-649.
15. Okuma, Y., Liu, K., Wake, H., Zhang, J., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Otani, N., Tomura, S., Shima, K., Yamamoto, Y., Yamamoto, H., Takahashi, H.K., Mori, S., and Nishibori, M. (2012). Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann. Neurol. 72, 373-384.
16. Su, X., Wang, H., Zhao, J., Pan, H., and Mao, L. (2011). Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-kappaB pathway after traumatic brain injury in the rat. Mediators Inflamm. 2011, 807142.
17. Gu, X.J., Xu, J., Ma, B.Y., Chen, G., Gu, P.Y., Wei, D., and Hu, W.X. (2014). Effect of glycyrrhizin on traumatic brain injury in rats and its mechanism. Chin. J. Traumatol. 17, 1-7.
18. Tang, D., Kang, R., Zeh, H.J. 3rd, and Lotze, M.T. (2011). Highmobility group box 1, oxidative stress, and disease. Antioxid. Redox. Signal 14, 1315-1335.
19. Zheng, Y., Gardner, S.E., and Clarke, M.C. (2011). Cell death, damageassociated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 31, 2781-2786.
20. Tehranian, R., Rose, M.E., Vagni, V., Griffith, R.P., Wu, S., Maits, S., Zhang, X., Clark, R.S., Dixon, C.E., Kochanek, P.M., Bernard, O., and Graham, S.H. (2006). Transgenic mice that overexpress the antiapoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury. Brain Res. 1101, 126-135.
21. Sinz, E.H., Kochanek, P.M., Dixon, C.E., Clark, R.S., Carcillo, J.A., Schiding, J.K., Chen, M., Wisniewski, S.R., Carlos, T.M., Williams, D., DeKosky, S.T., Watkins, S.C., Marion, D.W., and Billiar, T.R. (1999). Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J. Clin. Invest. 104, 647-656.
22. Statler, K.D., Alexander, H., Vagni, V., Holubkov, R., Dixon, C.E., Clark, R.S., Jenkins, L., and Kochanek, P.M. (2006). Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury. Brain Res. 1076, 216-224.
23. Busto, R., Dietrich, W.D., Globus, M.Y., Valdes, I., Scheinberg, P., and Ginsberg, M.D. (1987). Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7, 729-738.
24. Whalen, M.J., Clark, R.S., Dixon, C.E., Robichaud, P., Marion, D.W., Vagni, V., Graham, S.H., Virag, L., Hasko, G., Stachlewitz, R., Szabo, C., and Kochanek, P.M. (1999). Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADPribose) polymerase. J. Cereb. Blood Flow Metab. 19, 835-842.
25. Thomale, U.W., Griebenow, M., Kroppenstedt, S.N., Unterberg, A.W., and Stover, J.F. (2006). The effect of N-Acetylcysteine on posttraumatic changes after controlled cortical impact in rats. Intensive Care Med. 32, 149-155.
26. Kochanek, P.M., Marion, D.W., Zhang, W., Schiding, J.K., White, M., Palmer, A.M., Clark, R.S., O?Malley, M.E., Styren, S.D., Ho, C. and DeKosky, S.T. (1995). Severe controlled cortical impact in rats: Assessment of cerebral edema, blood flow, and contusion volume. J. Neurotrauma 12, 1015-1025.
27. Gyoneva, S. and Ransohoff, R.M. (2015). Inflammatory reaction after traumatic brain injury: Therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol. Sci. 36, 471-480.
28. Matzinger, P. (2002). The danger model: A renewed sense of self. Science 296, 301-305.
29. Park, J.S., Arcaroli, J., Yum, H.K., Yang, H., Wang, H., Yang, K.Y., Choe, K.H., Strassheim, D., Pitts, T.M., Tracey, K.J., and Abraham, E. (2003). Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell. Physiol. 284, C870-C879.
30. Chen, G., Zhang, S., Shi, J., Ai, J., Qi, M., and Hang, C. (2009). Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp. Neurol. 216, 398-406.
31. Chen, C.C., Hung, T.H., Wang, Y.H., Lin, C.W., Wang, P.Y., Lee, C.Y., and Chen, S.F. (2012). Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-kappaB signaling after experimental traumatic brain injury. PLoS One 7, e30294.
32. Ahmad, A., Crupi, R., Campolo, M., Genovese, T., Esposito, E. and Cuzzocrea, S. (2013). Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice. PLoS One 8, e57208.
33. Kawamata, T., Mori, T., Sato, S., and Katayama, Y. (2007). Tissue hyperosmolality and brain edema in cerebral contusion. Neurosurg. Focus 22, E5.
34. Wallisch, J., Jha, R., Farr, G., McGuirk, P., Pelletier, M., Jackson, T., Kochanek, P., and Manole, M. (2016). Aquaporin-4 inhibitor AER-271 blocks early cerebral edema in pediatric rat asphyxial cardiac arrest. Crit. Care Med. 44, 255.
35. Guazzi, S., Strangio, A., Franzi, A.T., and Bianchi, M.E. (2003). HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr. Patterns 3, 29-33.
36. Okun, E., Barak, B., Saada-Madar, R., Rothman, S.M., Griffioen, K.J., Roberts, N., Castro, K., Mughal, M.R., Pita, M.A., Stranahan, A.M., Arumugam, T.V., and Mattson, M.P. (2012). Evidence for a developmental role for TLR4 in learning and memory. PLoS One 7, e47522.
37. Zhu, D.Y., Liu, S.H., Sun, H.S., and Lu, Y.M. (2003). Expression of inducible nitric oxide synthase after focal cerebral ischemia stimulates neurogenesis in the adult rodent dentate gyrus. J. Neurosci. 23, 223-229.
38. Bayir, H., Kagan, V.E., Borisenko, G.G., Tyurina, Y.Y., Janesko, K.L., Vagni, V.A., Billiar, T.R., Williams, D.L., and Kochanek, P.M. (2005). Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS. J. Cereb. Blood Flow Metab. 25, 673-684.
39. Harris, H.E., Andersson, U., and Pisetsky, D.S. (2012). HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 8, 195-202.
40. Chavan, S.S., Huerta, P.T., Robbiati, S., Valdes-Ferrer, S.I., Ochani, M., Dancho, M., Frankfurt, M., Volpe, B.T., Tracey, K.J., and Diamond, B. (2012). HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 18, 930-937.
41. Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, P., Ferrari, S., and Bianchi, M.E. (1999). The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 22, 276-280.
42. Zhao, X., Kuja-Panula, J., Rouhiainen, A., Chen, Y.C., Panula, P., and Rauvala, H. (2011). High mobility group box-1 (HMGB1; amphoterin) is required for zebrafish brain development. J. Biol. Chem. 286, 23200-23213.
43. Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D., Yang, R., Czura, C.J., Fink, M.P., and Tracey, K.J. (2002). Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. U. S. A. 99, 12351-12356.
44. Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H.E., Susarla, S.M., Ulloa, L., Wang, H., DiRaimo, R., Czura, C.J., Wang, H., Roth, J., Warren, H.S., Fink, M.P., Fenton, M.J., Andersson, U. and Tracey, K.J. (2004). Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101, 296-301.